The Alberta Stroke Program Early CT Score (ASPECTS) is essential for clinical decision-making when treating ischemic stroke patients. It helps measure early ischemic changes and predict the functional outcome of endovascular thrombectomy.



Mastering the Art of Patient Transfer: Utilizing RapidAI Software for Seamlessly Transferring Patients to a Different Hospital
Neuroimaging has played a significant role in the stroke workflow following the DAWN and DEFUSE 3 trials and revised guidelines for acute ischemic stroke treatment. It helps determine which patients are eligible for endovascular thrombectomy (EVT) in the late window.

Optimal patient selection for endovascular thrombectomy procedure: CT Perfusion versus Non-contrast CT
Landmark stroke clinical trials DAWN and DEFUSE 3 helped validate the benefits of endovascular thrombectomy (EVT) procedure in acute ischemic stroke patients (AIS) in the late window. CT perfusion (CTP) aided in selecting eligible patients with a favorable perfusion profile.


Intracranial hemorrhage management with Rapid software
Rapid ICH 3.0 and Rapid Hyperdensity represent the best-in-class hemorrhagic solutions supporting clinicians managing intracranial hemorrhage (both hemorrhagic stroke and head trauma). Two studies presented at the International Stroke Conference (ISC) 2023 provide further clinical evidence of the value of these technologies.

Safety and efficacy of tenecteplase treatment in wake-up stroke patients screened using non-contrast CT
Based on current evidence, treatment with intravenous alteplase is recommended for patients with DWI-FLAIR mismatch or perfusion mismatch on CT or magnetic resonance perfusion. However, emergency rooms may have limited access to MRI or perfusion imaging.
